science is intact and we are getting close to know if the drug enhances chemo Given the faster recruitment/ willingness of patients, probability of patients staying on the trial past 28 days is high ... if that happens we will possibly know some early efficacy results
previously I was told that patients can stay on if they are willing to do so That info is not yet released to the market, and I am hoping they will release some info in the next quarterly
ATX Price at posting:
9.4¢ Sentiment: Buy Disclosure: Held
